Clinical Trials for Radiotherapy

Find clinical trials for radiotherapy. Discover research opportunities and treatment options in your area.

104 Active Trials Found

Showing 104 trials on this page

Page 2 of 6

Hypofractionated LocoRegional Radiotherapy in Breast Cancer

NCT ID: NCT04228991

This clinical trial is studying a new way of delivering radiation therapy for patients with breast cancer. Specifically, it is looking at a method called hypofractionated radiation therapy, which m...

Recruiting

Phase: PHASE3 Type: interventional Locations: Edmonton, Alberta, Canada, Saskatoon, Saskatchewan, Canada +19 more

TDLN-sparing RT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

NCT ID: NCT06964568

This clinical trial is studying a new treatment approach for patients with locally advanced esophageal squamous cell cancer (ESCC). The researchers want to find out if a type of radiotherapy that s...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, , China

Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)

NCT ID: NCT06923345

This clinical trial is looking at a new treatment approach for patients with advanced rectal cancer. The goal is to see if combining long-term radiation therapy, chemotherapy, and a type of immune ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer

NCT ID: NCT06926179

This clinical trial is looking at how safe and effective a type of treatment called neoadjuvant immunotherapy is for patients with non-small cell lung cancer (NSCLC). Neoadjuvant means that the tre...

Recruiting

Type: observational Locations: Beijing, Beijing, China, Beijing, Beijing, China +2 more

Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC

NCT ID: NCT06752239

This clinical trial is studying a new approach to radiotherapy for patients with nasopharyngeal carcinoma, which is a type of cancer that occurs in the throat area behind the nose. The goal is to s...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanchang, Jiangxi, China

Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: a Randomized Trial

NCT ID: NCT06805396

This clinical trial is studying how early access to palliative care can improve the quality of life and satisfaction with care for patients with bone metastases, which is a type of cancer that has ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Observational Study on Extreme Hypofractionation for Localized Prostate Cancer

NCT ID: NCT05344235

This clinical trial is studying a new way to treat localized prostate cancer using a method called extreme hypofractionation or stereotactic body radiotherapy (SBRT). This treatment delivers higher...

Recruiting

Type: observational Locations: Leuven, Vlaams Brabant, Belgium

Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy

NCT ID: NCT06201078

This clinical trial is studying a new treatment approach for men who have experienced a local recurrence of prostate cancer after having received prior radiotherapy. The researchers want to see if ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Gliwice, , Poland

Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma

NCT ID: NCT06864221

This clinical trial is studying how certain substances in the blood, called sphingolipids, might affect the success of radiotherapy in treating liver cancer, specifically hepatocellular carcinoma. ...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy

NCT ID: NCT06870942

This clinical trial is studying how effective and safe radiotherapy (a treatment that uses high-energy rays to target cancer) is for patients with hepatocellular carcinoma (HCC), a type of liver ca...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

NCT ID: NCT06256705

This clinical trial is studying a type of cancer called gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and how they respond to a treatment known as targeted radionuclide therapy (TRT). The...

Recruiting

Phase: NA Type: interventional Locations: Nantes, , France, Clichy, , France +5 more

NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy

NCT ID: NCT03589339

The clinical trial titled "NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy" is exploring a new treatment approach for patients with advanced ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Tampa, Florida, United States +14 more

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

NCT ID: NCT06353061

This clinical trial is studying whether adding metformin, a medication commonly used for diabetes, can help improve treatment outcomes for women with locally advanced cervical cancer. The researche...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, , China

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

NCT ID: NCT06758830

This clinical trial is exploring a new approach to treating rectal cancer, focusing on whether some patients can successfully avoid surgery by using a "watch-and-wait" strategy after receiving a co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Vilnius, , Lithuania

Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

NCT ID: NCT06768307

This clinical trial is studying a new treatment approach for patients with extensive-stage small cell lung cancer (ES-SCLC), a type of lung cancer that has spread beyond one side of the chest. The ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer

NCT ID: NCT06765616

This clinical trial is studying a new treatment approach for patients with locally advanced rectal cancer. Researchers want to see how well a combination of a medication called adebrelimab, short-c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer

NCT ID: NCT05673304

The IBISCO TRIAL is a research study looking at a new treatment approach for women with a specific type of breast cancer called Luminal B breast cancer. The goal of the trial is to see if adding a ...

Recruiting

Phase: NA Type: interventional Locations: Bologna, , Italy

PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy

NCT ID: NCT05055648

The PROTECT trial is studying a new way to treat esophageal cancer using a type of radiation therapy called proton therapy. Researchers believe that proton therapy can reduce radiation exposure to ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Paris, , France, Milan, , Italy +14 more

The Postoperative Radiotherapy in N1 Breast Cancer Patients

NCT ID: NCT05440149

This clinical trial is studying the effects of radiotherapy in women with breast cancer who have undergone surgery. Specifically, it compares two groups: one group will receive radiation therapy af...

Recruiting

Phase: PHASE3 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, Jongro Gu, Korea, Republic Of

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

NCT ID: NCT06708650

This clinical trial is studying a new treatment approach for patients with advanced liver cancer, specifically hepatocellular carcinoma (HCC), that cannot be surgically removed. The researchers are...

Not yet recruiting

Phase: NA Type: interventional Locations: Guiping, Guangxi, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions